[1]
J. Róg, “Omega-3 fatty acids in schizophrenia. Part II: Clinical applications”, Curr Probl Psychiatry, vol. 17, no. 4, pp. 261–271, Jan. 2017, doi: 10.1515/cpp-2016-0025.